Drug provocation tests in hypersensitivity drug reactions

Current Opinion in Allergy and Clinical Immunology

Volumn 11, Issue 4, 2011, Pages 299-304

  Rerkpattanapipat, Ticha ^a   Chiriac, Anca Mirela ^b   Demoly, Pascal ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

lactams; cross reactivity; drug hypersensitivity; drug provocation test; negative predictive value

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPENICILLIN; ANTINEOPLASTIC AGENT; ARTICAINE; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; DEXAMETHASONE; DIATER; HYDROCORTISONE; IMIPENEM; IMMUNOGLOBULIN E; IODINATED CONTRAST MEDIUM; LEUKOTRIENE RECEPTOR AFFECTING AGENT; LIDOCAINE; MEPIVACAINE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PENICILLIN G; PENICILLOYL POLYLYSINE; PREPEN; UNCLASSIFIED DRUG;

ASPIRIN EXACERBATED RESPIRATORY DISEASE; CANCER CHEMOTHERAPY; CYSTIC FIBROSIS; DESENSITIZATION; DIAGNOSTIC TEST ACCURACY STUDY; DRUG CROSS REACTIVITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MEDICAL SOCIETY; PATCH TEST; PATIENT SAFETY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SKIN TEST; TREATMENT INDICATION; TUBERCULOSIS; URTICARIA;

ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BETA-LACTAMS; CONTRAST MEDIA; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; GLUCOCORTICOIDS; HUMANS; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SKIN TESTS; TRIIODOBENZOIC ACIDS;

EID: 79960847678     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328348a4e9     Document Type: Review

References (55)

1. Demoly P, Bousquet J. Drug allergy diagnosis work up. Allergy 2002; 57 (Suppl 72):37-40. (Pubitemid 34970035)
2. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity. Allergy 2003; 58:854-863.
3. Aberer W, Kränke B. Provocation tests in drug hypersensitivity. Immunol Allergy Clin N Am 2009; 29:567-584.
4. Messaad D, Sahla H, Benahmed S, et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140:1001-1006.
5. Song EK, Seon JK, Jeong MS. Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement. J Bone Joint Surg (Br) 2010; 92-B:1596-1599.
6. Bousquet PJ, Gaeta F, Bousquet-Rouanet L, et al. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des 2008; 14:2792-2802.
7. Caimmi S, Galéra C, Bousquet-Rouanet L, et al. Safety of cefuroxime as an alternative in patients with a proven hypersensitivity to penicillins: a DAHD Cohort Survey. Int Arch Allergy Immunol 2010; 153:53-60.
8. Mori F, Barni S, Pucci N, et al. Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy. Ann Allergy Asthma Immunol 2010; 104:417-419.
9. Waton J, Tréchot P, Loss-Ayav C, et al. Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions. Br J Dermatol 2009; 160:786-794.
10. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259-273.
11. Kobashi Y, Abe T, Shigeto E, et al. Desensitization therapy for allergic reactions to antituberculous drugs. Inter Med 2010; 49:2297-2301.
12. Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122:574-580.
13. Brennan PJ, Bouza TR, Hsu FI, et al. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 2009; 124:1259-1266.
14. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64:183-193.
15. Torres MJ, Romano A, Mayorga C, et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001; 56:850-856. (Pubitemid 32800391)
16. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of b-lactam hypersensitivity. Clin Exp Allergy 2007; 38:185-190. (Pubitemid 350233388)
17. Bousquet PJ, Co-Minh HB, Arnoux B, et al. Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of b-lactam allergy. J Allergy Clin Immunol 2005; 115:1314-1316. (Pubitemid 40824609)
18. Torres MJ, Mayorga C, Leyva L, et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp All 2002; 32:270-276. (Pubitemid 34429607)
19. Torres MJ, Blanca M, Fernandez J, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-972. (Pubitemid 37260337)
20. Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmediate reactions to b-lactam antibiotics. Allergy 2004; 59:1153-1160. (Pubitemid 39389467)
21. Romano A, Guéant-Rodriguez RM, Viola M, et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005; 35:1234-1242.
22. Romano A, Gaeta F, Valluzz RL, et al. Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics 2008; 122:521-527.
23. Galera C, Kacimi D, Jolivet A, et al. Cephalosporin allergy: Interest in skin testing. Revue française d'allergologie 2010; 50:398-405.
24. Padial A, Antunezw C, Blanca-Lopez N, et al. Nonimmediate reactions to blactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38:822-828. (Pubitemid 351559564)
25. Rodriguez-Alvarez M, Santos-Magadan S, Rodriguez-Jimenez B, et al. Reproducibility of delayed-type reactions to betalactams. Allergol Immunopathol 2008; 36:201-204.
26. Blanca-Lopez N, Zapatero L, Alonso E, et al. Skin testing and drug provocation in the dianosis of nonimmediate reactions to aminopenicillins in children. Allergy 2009; 64:229-233.
27. Fernández TD, Canto G, Blanca M. Molecular mechanisms of maculopapular exanthema. Curr Opin Infect Dis 2009; 22:272-278.
28. Mayorga C, Torres MJ, Fernandez J, et al. Cutaneous symptoms in drug allergy: what have we learnt? Curr Opin Allergy Clin Immunol 2009; 9:431-436.
29. Chambel M, Martins P, Silva I, et al. Drug provocation tests to beta-lactam antibiotics: experience in a paediatric setting. Allergol Immunopathol (Madr) 2010; 38:300-306.
30. Solensky R, Earl HS, Gruchalla RS. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002; 162:822-826. (Pubitemid 34273307)
31. Goldberg A, Confino-Cohen R. Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy. Ann Allergy Asthma Immunol 2008; 100:37-43.
32. Ponvert C,Weilenmann C,Wassenberg J, et al. Allergy to betalactamantibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy 2007; 62:42-46. (Pubitemid 44902733)
33. Demoly P, Romano A, Botelho C, et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 2010; 65:327-332.
34. Fernadez TD, Torres MJ, Blanca-Lopez N, et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 2009; 64:242-248.
35. Matheu V, Perez-Rodriguez E, Sanchez-Machin I, et al. Importance of repeat testing in the diagnosis of penicillin allergy. Br J Dermatol 2006; 154:198. (Pubitemid 43381352)
36. Gallego Segovia M, García Dumpiérrez AM. Systemic reactions in anamnestic responses during penicillin allergy study. J Investig Allergol Clin Immunol 2009; 19:240-241.
37. Romano A, Guéant-Rodriguez RM, Viola M, et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004; 141:16-22.
38. Atanaskovic-Markovic M, Gaeta F, Medjo B, et al. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins. Allergy 2008; 63:237-240.
39. Schiavino D, Nucera E, Lombardo C, et al. Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to b-lactams. Allergy 2009; 64:1644-1648.
40. Romano A, Gaeta F, Valluzzi RL, et al. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems. J Allergy Clin Immunol 2010; 126:994-999.
41. Gómez E, Blanca-Lopez N, Torres MJ, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39:1217-1224.
42. Canto MG, Andreu I, Fernandez J, Blanca M. Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009; 9:293-297.
43. Viola M, Rumi G, Valluzzi RL, et al. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy 2011; 41:96-103.
44. Dursun AB, Woessner KA, Simon RA, et al. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol 2008; 100:420-425. (Pubitemid 351668776)
45. Doñ a I, Blanca-López N, Cornejo-García JA, et al. Characteristics of subjects experiencing hypersensitivity to nonsteroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41:86-95.
46. Hope AP, Woessner KA, Simon RA, Stevenson DD. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2009; 123: 406-410.
47. Caimmi S, Benyahia B, Suau D, et al. Clinical value of negative skin tests to iodinated contrast media. Clin Exp Allergy 2010; 40:805-810.
48. Seitz CS, Pfeuffer P, Raith R, et al. Radiocontrast media-associated exanthema: identification of cross-reactivity and tolerability by allergologic testing. Eur J Radiol 2009; 72:167-171.
49. Caimmi S, Caimmi D, Bousquet PJ, Demoly P. Succinate as opposed to glucocorticoid itself allergy. Allergy 2008; 63:1641-1643.
50. de Sousa NG, Santa-Marta C, Morais-Almeida M. Systemic corticosteroid hypersensitivity in children. J Investig Allergol Clin Immunol 2010; 20:529-532.
51. Aranda A, Mayorga C, Ariza A, et al. IgE-mediated hypersensitivity reactions to methylprednisolone. Allergy 2010; 65:1376-1380.
52. Fuzier R, Lapeyre-Mestre M, Mertes PM, et al. Immediate- and delayed-type allergic reactions to amide local anesthetics: clinical features and skin testing. Pharmacoepidemiol Drug Saf 2009; 18:595-601.
53. Harboe T, Guttormsen AB, Aarebrot S, et al. Suspected allergy to local anaesthetics: follow-up in 135 cases. Acta Anaesthesiol Scand 2010; 54: 536-542.
54. Gomes ER, Kvedariene V, Demoly P, Bousquet PJ. Patients' satisfaction with diagnostic drug provocation tests and perception of its usefulness. Int Arch Allergy Immunol (in press).
55. Waton J, Pouget-Jasson C, Loos-Ayav C, et al. Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patients. Allergy 2011. doi: 10.1111/j.1398-9995.2011. 02554.x.